Jefferies Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,623
| Closed | -$4.2M | – | 1395 |
|
|
2025
Q1 | $4.2M | Sell |
6,623
-29,199
| -82% | -$18.5M | 0.04% | 254 |
|
|
2024
Q4 | $25.5M | Buy |
35,822
+8,327
| +30% | +$5.93M | 0.15% | 60 |
|
|
2024
Q3 | $28.9M | Buy |
27,495
+7,004
| +34% | +$7.36M | 0.21% | 30 |
|
|
2024
Q2 | $21.5M | Buy |
20,491
+11,851
| +137% | +$12.5M | 0.23% | 42 |
|
|
2024
Q1 | $8.32M | Buy |
8,640
+840
| +11% | +$808K | 0.08% | 117 |
|
|
2023
Q4 | $6.85M | Buy |
7,800
+5,500
| +239% | +$4.83M | 0.04% | 182 |
|
|
2023
Q3 | $1.89M | Sell |
2,300
-7,300
| -76% | -$6.01M | 0.02% | 383 |
|
|
2023
Q2 | $6.9M | Sell |
9,600
-3,275
| -25% | -$2.35M | 0.06% | 143 |
|
|
2023
Q1 | $10.6M | Buy |
12,875
+12,327
| +2,249% | +$10.1M | 0.09% | 99 |
|
|
2022
Q4 | $395K | Buy |
+548
| New | +$395K | ﹤0.01% | 719 |
|
|
2019
Q1 | – | Sell |
-10,522
| Closed | -$3.93M | – | 49 |
|
|
2018
Q4 | $3.93M | Buy |
+10,522
| New | +$3.93M | 0.46% | 14 |
|
|
2018
Q3 | – | Sell |
-11,819
| Closed | -$4.08M | – | 93 |
|
|
2018
Q2 | $4.08M | Buy |
11,819
+6,110
| +107% | +$2.11M | 0.31% | 34 |
|
|
2018
Q1 | $1.97M | Buy |
+5,709
| New | +$1.97M | 0.14% | 39 |
|